Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017.

MLA

Gaglani, Manjusha, et al. “Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017.” Clinical Infectious Diseases, vol. 72, no. 7, Apr. 2021, pp. 1147–57. EBSCOhost, https://doi.org/10.1093/cid/ciaa102.

APA

Gaglani, M., Vasudevan, A., Raiyani, C., Murthy, K., Chen, W., Reis, M., Belongia, E. A., McLean, H. Q., Jackson, M. L., Jackson, L. A., Zimmerman, R. K., Nowalk, M. P., Monto, A. S., Martin, E. T., Chung, J. R., Spencer, S., Fry, A. M., & Flannery, B. (2021). Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017. Clinical Infectious Diseases, 72(7), 1147–1157. https://doi.org/10.1093/cid/ciaa102

Chicago

Gaglani, Manjusha, Anupama Vasudevan, Chandni Raiyani, Kempapura Murthy, Wencong Chen, Michael Reis, Edward A Belongia, et al. 2021. “Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017.” Clinical Infectious Diseases 72 (7): 1147–57. doi:10.1093/cid/ciaa102.